641 results on '"Sang, Xinting"'
Search Results
2. Novel multifactor predictive model for postoperative survival in gallbladder cancer: a multi-center study
3. Liver fibrosis as a predictor of liver failure and outcome following ALPPS among patients with primary liver cancer
4. Retraction Note: The effects of intermittent bolus paravertebral block on analgesia and recovery in open hepatectomy: a randomized, double-blinded, controlled study
5. Gut microbiota and metabolites signatures of clinical response in anti-PD-1/PD-L1 based immunotherapy of biliary tract cancer
6. Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study
7. Urinary biomarkers for hepatocellular carcinoma: current knowledge for clinicians
8. RETRACTED ARTICLE: The effects of intermittent bolus paravertebral block on analgesia and recovery in open hepatectomy: a randomized, double-blinded, controlled study
9. Development and validation of a selenium metabolism regulators associated prognostic model for hepatocellular carcinoma
10. Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients
11. LINC02257 regulates colorectal cancer liver metastases through JNK pathway
12. Radiation Therapy With Combination Therapy of Immune Checkpoint Inhibitors and Antiangiogenic Therapy for Hepatocellular Carcinoma
13. Unravelling the liver-brain connection: A two-sample Mendelian randomization study investigating the causal relationship between NAFLD and cortical structure
14. Co-expression of receptor tyrosine kinases and CD8 T-lymphocyte genes is associated with distinct prognoses, immune cell infiltration patterns and immunogenicity in cancers
15. Immunotherapy prototype Mark 3.0 model in primary liver cancer: adding locoregional stereotactic therapy and prognostic factors classification management
16. Research on liquid biopsy for cancer: A bibliometric analysis
17. Interpretation on the Updated Points of Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)
18. Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma
19. A real-world study of the efficacy and safety of anti-PD-1 antibodies plus lenvatinib in patients with advanced gallbladder cancer
20. A novel cuproptosis-related gene signature for overall survival prediction in patients with hepatocellular carcinoma
21. Evolution of associating liver partition and portal vein ligation for staged hepatectomy from 2012 to 2021: A bibliometric analysis. Review
22. A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape
23. A novel nomogram based on log odds of positive lymph nodes to predict survival for non-metastatic gallbladder adenocarcinoma after surgery
24. Ultrasound-Guided Continuous Thoracic Paravertebral Block Improves Patient's Quality of Recovery After Open Hepatectomy: A Randomized, Double-Blind, Placebo-Controlled Trial
25. Novel Multi-factor Predictive Model for Postoperative Survival in Gallbladder Cancer: A Multi-Center Study
26. Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine
27. Unique TP53 neoantigen and the immune microenvironment in long-term survivors of Hepatocellular carcinoma
28. Laparoscopic caudate lobectomy: a multicenter, propensity score-matched report of safety, feasibility, and early outcomes
29. Comparison of Prognostic Value of Red Cell-Related Parameters of Biliary Tract Cancer After Surgical Resection and Integration of a Prognostic Nomogram: A Retrospective Study
30. Association of Breast Density With Risk of Breast Cancer
31. Efficacy and safety of subsequent radiotherapy in patients with advanced-stage hepatocellular carcinoma treated with immune checkpoint inhibitors
32. Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapy
33. Comprehensive analysis of coagulation indices for predicting survival in patients with biliary tract cancer
34. A methodological investigation of healthy tissue, hepatocellular carcinoma, and other lesions with dynamic 68Ga-FAPI-04 PET/CT imaging
35. Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer
36. Immune checkpoint inhibitor‐related molecular markers predict prognosis in extrahepatic cholangiocarcinoma
37. Time-restricted feeding causes irreversible metabolic disorders and gut microbiota shift in pediatric mice
38. The effects of intermittent bolus paravertebral block on analgesia and recovery in open hepatectomy: a randomized, double-blinded, controlled study
39. Intratumoural microbiome can predict the prognosis of hepatocellular carcinoma after surgery
40. Radiotherapy with Combination Therapy of Immune Checkpoint Inhibitors and Anti-Angiogenic Therapy for Hepatocellular Carcinoma
41. Integrated analysis of serum lipid profile for predicting clinical outcomes of patients with malignant biliary tumor
42. Prediction of Clinical Precision Chemotherapy by Patient‐Derived 3D Bioprinting Models of Colorectal Cancer and Its Liver Metastases.
43. Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis
44. Metabolic Tumor Volume Measured by 18F-FDG PET/CT is Associated with the Survival of Unresectable Hepatocellular Carcinoma Treated with PD-1/PD-L1 Inhibitors Plus Molecular Targeted Agents
45. Supplementary Figure S1-S3. from Alterations in DNA Damage Repair Genes in Primary Liver Cancer
46. Supplementary Table S1-S4. from Alterations in DNA Damage Repair Genes in Primary Liver Cancer
47. Local-regional therapy combined with toripalimab and lenvatinib in patients with advanced biliary tract cancer
48. Prognostic value of SAT volume and density for predicting the outcome of patients with unresectable HCC treated with lenvatinib plus anti-PD-1 antibodies
49. Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies
50. Application and Progress of Cultured Models of Gallbladder Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.